Tybourne

Flush with $165M IPO cash, Zentalis entices Tybourne, OrbiMed to fund a $20M China joint venture
Endpoints
Wed, 05/20/20 - 10:48 am
Zentalis
China
IPOs
Tybourne
OrbiMed